Cargando…

Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein

The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myelin sheath of brain oligodendrocytes. For the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamaeva, Daria A., Smirnova, Liudmila P., Vasilieva, Svetlana N., Kazantseva, Daria V., Vasilieva, Alisa R., Ivanova, Svetlana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267049/
https://www.ncbi.nlm.nih.gov/pubmed/35806400
http://dx.doi.org/10.3390/ijms23137397
_version_ 1784743620117528576
author Kamaeva, Daria A.
Smirnova, Liudmila P.
Vasilieva, Svetlana N.
Kazantseva, Daria V.
Vasilieva, Alisa R.
Ivanova, Svetlana A.
author_facet Kamaeva, Daria A.
Smirnova, Liudmila P.
Vasilieva, Svetlana N.
Kazantseva, Daria V.
Vasilieva, Alisa R.
Ivanova, Svetlana A.
author_sort Kamaeva, Daria A.
collection PubMed
description The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myelin sheath of brain oligodendrocytes. For the first time, we have shown that IgGs isolated from sera of bipolar patients can effectively hydrolyze human myelin basic protein (MBP), unlike other test proteins. Several stringent criteria were applied to assign the studied activity to serum IgG. The level of MBP-hydrolyzing activity of IgG from patients with bipolar disorder was statistically significantly 1.6-folds higher than that of healthy individuals. This article presents a detailed characterization of the catalytic properties of MBP-hydrolyzing antibodies in bipolar disorder, including the substrate specificity, inhibitory analysis, pH dependence of hydrolysis, and kinetic parameters of IgG-dependent MBP hydrolysis, providing the heterogeneity of polyclonal MBP-hydrolyzing IgGs and their difference from canonical proteases. The ability of serum IgG to hydrolyze MBP in bipolar disorder may become an additional link between the processes of myelin damage and inflammation.
format Online
Article
Text
id pubmed-9267049
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92670492022-07-09 Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein Kamaeva, Daria A. Smirnova, Liudmila P. Vasilieva, Svetlana N. Kazantseva, Daria V. Vasilieva, Alisa R. Ivanova, Svetlana A. Int J Mol Sci Article The pathogenesis of bipolar affective disorder is associated with immunological imbalances, a general pro-inflammatory status, neuroinflammation, and impaired white matter integrity. Myelin basic protein (MBP) is one of the major proteins in the myelin sheath of brain oligodendrocytes. For the first time, we have shown that IgGs isolated from sera of bipolar patients can effectively hydrolyze human myelin basic protein (MBP), unlike other test proteins. Several stringent criteria were applied to assign the studied activity to serum IgG. The level of MBP-hydrolyzing activity of IgG from patients with bipolar disorder was statistically significantly 1.6-folds higher than that of healthy individuals. This article presents a detailed characterization of the catalytic properties of MBP-hydrolyzing antibodies in bipolar disorder, including the substrate specificity, inhibitory analysis, pH dependence of hydrolysis, and kinetic parameters of IgG-dependent MBP hydrolysis, providing the heterogeneity of polyclonal MBP-hydrolyzing IgGs and their difference from canonical proteases. The ability of serum IgG to hydrolyze MBP in bipolar disorder may become an additional link between the processes of myelin damage and inflammation. MDPI 2022-07-02 /pmc/articles/PMC9267049/ /pubmed/35806400 http://dx.doi.org/10.3390/ijms23137397 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kamaeva, Daria A.
Smirnova, Liudmila P.
Vasilieva, Svetlana N.
Kazantseva, Daria V.
Vasilieva, Alisa R.
Ivanova, Svetlana A.
Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein
title Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein
title_full Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein
title_fullStr Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein
title_full_unstemmed Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein
title_short Catalytic Antibodies in Bipolar Disorder: Serum IgGs Hydrolyze Myelin Basic Protein
title_sort catalytic antibodies in bipolar disorder: serum iggs hydrolyze myelin basic protein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267049/
https://www.ncbi.nlm.nih.gov/pubmed/35806400
http://dx.doi.org/10.3390/ijms23137397
work_keys_str_mv AT kamaevadariaa catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein
AT smirnovaliudmilap catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein
AT vasilievasvetlanan catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein
AT kazantsevadariav catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein
AT vasilievaalisar catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein
AT ivanovasvetlanaa catalyticantibodiesinbipolardisorderserumiggshydrolyzemyelinbasicprotein